Please login to the form below

Not currently logged in
Email:
Password:

Sirturo

This page shows the latest Sirturo news and features for those working in and with pharma, biotech and healthcare.

AZ, BMS and Boehringer among UK Prix Galien finalists

AZ, BMS and Boehringer among UK Prix Galien finalists

Janssen's Sirturo, the first tuberculosis medication to be approved in four decades.

Latest news

  • UK Prix Galien opens for entries UK Prix Galien opens for entries

    The 2014 UK Prix Galien was won by Bexsero,  the first ever vaccine to treat invasive meningococcal disease, and Sirturo,  the first TB medication to be approved in four decades.

  • Study shows Otsuka's TB drug works even in worst cases Study shows Otsuka's TB drug works even in worst cases

    Deltyba was approved for marketing last year in Europe, joining Johnson &Johnson's Sirturo (bedaquiline) as the first new therapies for multidrug-resistant TB in decades. .

  • Novartis' Bexsero triumphs at UK Prix Galien Novartis' Bexsero triumphs at UK Prix Galien

    The Awards also saw Janssen's Sirturo pick up the Orphan Drug prize. ... Orphan Drug award for Janssen's Sirturo. Pictured (l-r): Dr Ramesh Dass - Janssen's European commercial lead for Sirturo, Sir Kevin Barron MP, Dr Peter Barnes - Janssen's UK Medical

  • Otsuka wins approval for TB drug Deltyba Otsuka wins approval for TB drug Deltyba

    This week the European Commission granted the Japanese firm authorisation to market Deltyba (delamanid) almost two months after backing Johnson &Johnson's Sirturo (bedaquiline) in a similar indication.

  • J&J gets EU green light for novel TB drug J&J gets EU green light for novel TB drug

    Sirturo approved to treat multidrug resistant form of the disease. Johnson &Johnson has secured approval in Europe for Sirturo, one of the first new classes of tuberculosis (TB) therapy to reach ... The EC has granted a license for Sirturo (bedaquiline)

More from news
Approximately 4 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • The world is our laboratory The world is our laboratory

    We developed Sirturo (bedaquiline), the first new medicine for tuberculosis in 40 years, which received the UK Prix Galien Award for most innovative orphan drug in October 2014.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics